Investment Pitches

Pitch Summary:
Getbusy plc is considered a speculative investment with the potential for significant returns, possibly 2-4x in three years. The company's focus on document management and productivity solutions taps into growing market demand. Despite its speculative nature, the potential upside makes it an intriguing addition to the portfolio. The investment thesis is based on the company's innovative product offerings and market expansion opportunities.

BSD Analysis:
Getbusy plc's strategic positioning in the document management sector offers substantial growth potential. The company's innovative approach to productivity solutions aligns with increasing digital transformation trends. While speculative, the investment is supported by a clear growth trajectory and market demand. The potential for high returns is balanced by the inherent risks, making it suitable for investors with a higher risk tolerance. Overall, Getbusy plc represents an opportunity to capitalize on emerging market trends and technological advancements.

Pitch Summary:
Computer Modelling Group is poised for growth in 2026 as its strategy 4.0 begins to gain traction. The company's focus on innovative software solutions for the oil and gas sector positions it well for increased demand. Its capital allocation strategy is expected to drive higher valuations, making it an attractive investment. The company's strong market position and technological advancements support a bullish outlook.

BSD Analysis:
The implementation of strategy 4.0 is a pivotal moment for Computer Modelling Group, potentially unlocking new revenue streams and market opportunities. The company's commitment to innovation and client-centric solutions enhances its competitive edge in the software industry. As the energy sector evolves, Computer Modelling Group's offerings are likely to see increased adoption, driving growth. The strategic focus on capital allocation underscores management's confidence in delivering shareholder value. Overall, the investment thesis is supported by the company's strong fundamentals and growth prospects.

Pitch Summary:
Kelly Partners Group is a top pick for 2026 due to its strong leadership and strategic direction under CEO Brett Kelly. The company is positioned to capitalize on its robust capital allocation strategy, which is expected to enhance its valuation. The recent purchase at 7.85 AUD reflects confidence in its growth potential. Despite market fluctuations, Kelly Partners Group remains a cornerstone of the portfolio, indicating a long-term bullish outlook.

BSD Analysis:
The decision to increase the allocation in Kelly Partners Group highlights its perceived undervaluation and potential for significant appreciation. The company's focus on quality service delivery and strategic acquisitions supports its growth trajectory. The leadership's commitment to shareholder value and disciplined financial management further strengthens the investment thesis. The professional services sector's resilience and demand for high-quality advisory services provide a stable backdrop for Kelly Partners Group's expansion. Overall, the investment aligns with a strategy focused on quality and long-term value creation.

Pitch Summary:
@weary_centurion frames PayPal as an incumbent that must re-earn investor trust in 2026, arguing sentiment has deteriorated due to perceived complacency and weak communication. The core setup is an earnings/guidance “decision point” where Q4 results and 2026 outlook determine whether management is quietly executing a reset or masking underlying weakness. The author outlines specific shareholder-friendly actions—cost cuts, faster buybacks, and improved SBC discipline—implying capital allocation and operating leverage are key near-term levers. They also flag competitive anxiety (disruption risk) and relative macro sensitivity versus peers as the primary fundamental questions the market will judge. Upside surprise scenarios focus on stronger free cash flow, a return to healthier revenue growth, traction in ads, and visible operational streamlining. The risk is that soft Q4 prints or cautious guidance would represent a transparency failure and could trigger an exit. Overall, it’s a conditional bull stance: stay long into the catalyst, reassess immediately after Q4 and 2026 guide.

BSD Analysis:
PayPal’s near-term debate is less about “payments TAM” and more about mix, pricing power, and whether product velocity restores branded engagement while maintaining unbranded profitability. The market will likely reward proof of operating discipline (SBC containment, opex leverage) only if it coincides with stable take rates and durable transaction margin dollars—otherwise buybacks can look like financial engineering against a deteriorating core. Competitive pressure is structurally asymmetric: wallets and big-tech rails can compress checkout economics, while enterprise PSP competition (e.g., modern gateways) pushes pricing toward “value-added” differentiation (fraud, authorization lift, conversion). Ads is directionally attractive because it monetizes intent and data, but investors will demand evidence of scalable merchant demand and measurable ROI rather than narrative. The key underwriting question is earnings power through a normalized cycle: can PYPL hold transaction margin while growing higher-margin services enough to expand operating margin? Watch for leading indicators: branded checkout growth vs. unbranded, take-rate stability, incremental margin on revenue re-acceleration, and whether buybacks are funded from sustainably growing FCF after SBC. If management guides to credible acceleration with disciplined spend, the multiple can rerate quickly; if not, the stock can remain trapped as a “mature processor” valued on yield rather than growth.

Actual Post Content:
$PYPL THOUGHTS FOR 2026 PayPal have got work to do Shareholders are pissed and rightly so Next year they need to prove to the market that they are not a bloated, complacent incumbent primed for disruption If I was them I would: - Aggressively cut headcount - Accelerate buybacks - Change SBC incentives - Reduce SBC further - Execute insider buys Radio silence has not helped recently But Q4 is where we find out what the purpose for this silence is For me, it indicates one of two things: 1. Things are bad and they don’t want to talk about it 2. They are pissed and furiously working to make 2026 a blowout year If Q4 is strong and 2026 guidance is aggressive, then we know it will be number 2 If Q4 is poor and guidance is pessimistic, then that is a warning sign and at that point I would consider exiting the stock because that would be a huge red flag for lack of transparency Buybacks and share count are the floor for the stock, but they aren’t the thesis The company needs to be doing well too My main concerns are: Red Is PayPal being affected by macro much more than competitors Red Is PayPal being disrupted more than they are letting on Red Lack of effective capital allocation (no buybacks acceleration) Q4 will be the benchmark and a lot hinges on 2026 guidance The things that could surprise the market: Green Strong FCF and yearly ATH Green Strong revenue growth (8-10%) Green Update on PayPal Ads Green Headcount reduction announcement Green Raft of shares bought back Overall I am far less excited about 2026 than I was just a few weeks ago, but a fair bit has changed since then I will wait for Q4 before I decide whether this investment is still worthwhile for 2026 Nothing is off the table depending on what we learn Not financial advice Jury is out until 2024 I agree on lack of noise as long as they are executing but until Q4 we are sort of in the dark on that All we have is bearish commentary from management since Q3 and 2026 guidance in question This is where I will give them credit, it’s excellent Not sure about adoption though as there was no wide ranging ad campaign, friends and family are learning for the first time about the debit card and all seem keen to get it but hard to say whether this is being replicated across the rest of the UK I will try and do some research to find out Agree tbh All the best handshake Me too OK Agree, decisive action is required I hope so laugh

URL: https://x.com/weary_centurion/status/2006395480758964567

Pitch Summary:
@aleabitoreddit highlights Tesla as a long-term beneficiary of soft robotics as humanoid systems evolve beyond rigid mechanical constraints. The business model leverages vertically integrated hardware paired with AI-driven control systems. The catalyst is convergence of advanced materials with LLM-based cognition. Valuation is framed as optionality rather than near-term earnings. Risks include execution complexity and commercialization timelines. The stance is Bull based on Tesla’s scale and AI integration advantage.

BSD Analysis:
Tesla’s robotics effort represents an extension of its AI and manufacturing stack rather than a standalone product cycle. Soft robotics could expand addressable markets but monetization remains uncertain. Competitive advantages lie in data, compute, and real-world deployment. Execution risk is high given hardware complexity. This is a long-duration optionality investment.

Actual Post Content:
2026 Newsletter. Thematic Investments: Evolution, Disruption, and Bottlenecks Soft Robotics Evolution to TSLA ONDS Boston Dynamics This is a light overview of thematic investments I find the most interesting from a public-information synthesis perspective plus second and third-order effects from bottlenecks Soft Robotics The Evolution to Robotics Traditional robotics Optimus Boston Dynamics relies on Inverse Kinematics to rigid joints Soft robotics changes the math We've met the point where hardware Optimus Boston Dynamics Figure met LLMs Gemini Grok Opus and we're at the beginning of possible widespread commercialization By using materials inspired by octopus tentacles and human skin robots are moving away from gears and toward fluidity Possibilities are limitless adding organism-like fluidity to rigid robotics this is just the natural evolution

URL: https://x.com/aleabitoreddit/status/2006709693012467774

Pitch Summary:
Harbour Energy is a UK oil major with a strong production base and proven reserve replacement capability. The company generated significant free cash flow in 2025, which is being used for dividends, buybacks, and acquisitions. Its valuation and genuine dividend yield make it an attractive investment in the energy sector.

BSD Analysis:
Despite oil price volatility and regulatory challenges, Harbour Energy's low cost base and diverse geographic footprint provide downside protection. The company's capital discipline and strategic focus on accretive acquisitions position it well for long-term growth. Investors should monitor regulatory changes and energy transition pressures that could impact future profitability.

Pitch Summary:
Hoyne Bancorp's recent mutual-to-stock conversion offers unique capital deployment opportunities, with the stock trading at 0.66x tangible book value. The conversion provides optionality for future growth and acquisitions, with potential for re-rating as the market recognizes the value of the post-conversion entity.

BSD Analysis:
The mutual conversion process typically leads to valuation expansion over 12-24 months as the market adjusts to the new capital structure. While thrift banks face challenges in rising rate environments, Hoyne's conversion creates optionality for strategic growth. Investors should consider the bank's interest rate sensitivity and potential acquisition targets when evaluating its prospects.

Pitch Summary:
Victory Square offers investors access to a portfolio of early-stage tech and digital health companies with public-market liquidity. The company's main investment, Hydreight, is valued higher than its entire market cap, presenting a significant opportunity if the market recognizes its asset value.

BSD Analysis:
The concentration of Victory Square's portfolio in Hydreight poses a risk, as any disappointment could impact the overall valuation. However, the company's strategy of providing public-market access to venture investments offers unique exposure to high-growth sectors. Investors should treat this as a speculative investment, considering the potential for significant returns alongside inherent risks.

Pitch Summary:
Cronos Group is positioned to benefit from potential US cannabis legalization, which could re-rate the entire sector. The company's strong cash position and Canadian profitability demonstrate its ability to generate real earnings. Covered call strategies on CRON offer attractive premiums while maintaining exposure to long-term legalization catalysts.

BSD Analysis:
The cannabis sector remains volatile, with regulatory uncertainty and competitive pressures impacting margins. However, Cronos's financial stability and strategic positioning in the Canadian market provide a solid foundation for growth. Investors should consider the macroeconomic environment and consumer spending trends when evaluating the company's prospects.

Pitch Summary:
uniQure's AMT-130 gene therapy for Huntington's disease has shown a 75% slowing of disease progression in trials, marking a significant breakthrough in neurodegeneration treatment. The therapy's potential for global approval presents a substantial market opportunity, with Europe likely leading the way in regulatory acceptance.

BSD Analysis:
The success of AMT-130 in clinical trials positions uniQure as a leader in gene therapy for neurodegenerative diseases. While the development process is capital-intensive and subject to regulatory challenges, the therapy's unprecedented results offer a compelling risk/reward profile. Investors should be aware of the potential for extended timelines and additional clinical work due to regulatory pathway changes.

Pitch Summary:
Qifu Technology is a capital-light credit-tech platform that has pivoted towards higher-margin platform revenue amidst regulatory tightening. The market's panic has led to a valuation dislocation, with QFIN trading at less than 2 P/E. The company's shift away from full-payment-guarantee loans reduces credit risk while maintaining profitability through SaaS-like revenue streams.

BSD Analysis:
China's fintech regulations are stabilizing, providing a more predictable environment for Qifu's operations. The company's focus on AI-enhanced loan servicing and platform revenue positions it well for future growth. While regulatory surprises and macroeconomic pressures remain risks, Qifu's strong cash generation and sustainable buybacks offer a compelling investment case.

Pitch Summary:
Compass Diversified Holdings is in a distressed situation following a fraud incident at Lugano Diamonds, leading to a collapse in share price. With Lugano being deconsolidated, investors can focus on the remaining subsidiaries, which continue to generate strong cash flows. Analysts value the 'RemainCo' at over $10 per share, suggesting significant upside from current levels.

BSD Analysis:
The deconsolidation of Lugano Diamonds allows for a clearer valuation of Compass's remaining portfolio, which includes profitable subsidiaries like 5.11 Tactical and Boa Technology. While the situation is high-risk due to lender forbearance and potential asset sales, the underlying businesses remain strong. Investors should conduct thorough due diligence given the complexity and risks involved.

Pitch Summary:
Galaxy Gaming is trading at $2.80 with an ongoing merger agreement with Evolution Malta at $3.20 per share. The 14% arbitrage spread reflects market skepticism about the merger's completion timeline and regulatory risks. However, with most regulatory approvals secured, the strategic rationale for the acquisition is strong, offering immediate US gaming exposure for Evolution without integration risks.

BSD Analysis:
The merger's all-cash nature and absence of financing conditions reduce execution risks, while the remaining regulatory approvals are progressing. The potential downside is significant if the deal is terminated, as the stock could revert to pre-announcement levels. However, the visible execution timelines and strategic benefits for Evolution make this an attractive arbitrage opportunity.

Pitch Summary:
Vistry Group is undergoing a strategic transformation from traditional housebuilding to a partnerships model, collaborating with housing associations and local authorities on pre-sold affordable housing projects. This shift is overlooked by the market, which is focused on macroeconomic headwinds. The company's strong government relationships and modular construction capabilities position it as a leader in addressing the UK's structural housing shortage.

BSD Analysis:
The partnerships model reduces capital requirements and enhances Vistry's ability to navigate economic fluctuations. While the traditional business model's runoff must be managed effectively, the company's focus on affordable housing aligns with government priorities, providing a competitive advantage. Risks include potential government funding cuts and planning delays, but Vistry's strategic pivot offers significant long-term growth potential.

Pitch Summary:
Regional REIT is trading at a 50% discount to its net asset value, offering a 9.5% dividend yield. The market's negative sentiment towards UK REITs due to interest rate concerns and structural headwinds has created a buying opportunity. If sentiment stabilizes and institutional investors recognize the asset value, RGL could experience a significant re-rating while providing a stable income stream.

BSD Analysis:
The current NAV discount in Regional REIT reflects temporary market sentiment rather than a fundamental deterioration of its assets. The company's stable rental income and the market's mispricing of collateral impairment present a compelling investment case. However, the sustainability of dividends relies on continued rent collection amidst genuine headwinds in the UK commercial property sector. The opportunity lies in the potential for sentiment recovery and asset value recognition.

Pitch Summary:
Medicenna is advancing a groundbreaking IL-2 immunotherapy program in oncology with its MDNA11 candidate, which has shown unprecedented efficacy across multiple solid tumors without the toxicity issues that plagued previous IL-2 therapies. The market has mispriced the clinical potential of MDNA11, which could significantly expand its addressable market to over $10 billion if it demonstrates durable response rates and moves into earlier disease settings.

BSD Analysis:
The NEO-CYT trial is strategically designed to overcome skepticism surrounding IL-2 therapies by providing robust data. While the biotech sector is inherently risky with potential execution challenges like clinical trial delays and regulatory hurdles, Medicenna's approach addresses these concerns. The potential for MDNA11 to reverse immune system failure represents a significant breakthrough in cancer treatment, and successful trial outcomes could lead to substantial market revaluation.

Pitch Summary:
ASML has a monopoly in EUV lithography, but its growth projection for next year is mid-single digit. The company's inability to deliver to China and its dependence on the AI CAPEX boom are concerns. With a PEG ratio of 6, the stock is overvalued. The decision to reduce holdings is based on the desire to decouple from the AI CAPEX boom due to its unsustainability and unpredictability.

BSD Analysis:
ASML's dominant position in the semiconductor equipment market is offset by its high valuation and reliance on the AI CAPEX boom. The inability to deliver to China limits growth opportunities, and the high PEG ratio indicates overvaluation. The decision to reduce holdings is strategic, aimed at minimizing exposure to the AI CAPEX boom and reallocating capital to more stable investments. The company's growth prospects are uncertain, making it a less attractive investment at this time.